TB-500
£29.99
TB-500 is a synthetic peptide that corresponds to a fragment of thymosin beta-4 (Tβ4), a naturally occurring protein involved in tissue repair, cell migration, and wound healing. It has been studied extensively in preclinical research for its potential regenerative and reparative properties.
TB-500 – Educational Overview
For Informational & Research Purposes Only.
What Is TB-500?
TB-500 is a synthetic peptide that corresponds to a fragment of thymosin beta-4 (Tβ4), a naturally occurring protein involved in tissue repair, cell migration, and wound healing. It has been studied extensively in preclinical research for its potential regenerative and reparative properties.
It is not approved by the U.S. Food and Drug Administration (FDA) for therapeutic or clinical use in humans or animals outside regulated research settings.
Research Background
TB-500 has been investigated primarily in laboratory and animal studies, focusing on:
-
Tendon, ligament, and muscle repair
-
Wound healing and tissue regeneration
-
Angiogenesis (formation of new blood vessels)
-
Cell migration and cytoskeletal organization
Most research is preclinical, and high-quality clinical trials in humans are limited.
Proposed Mechanism of Action (Scientific Context)
Experimental studies suggest TB-500 may work by:
-
Enhancing cell migration to injured tissues, promoting faster repair
-
Stimulating angiogenesis, improving blood supply to damaged areas
-
Modulating the actin cytoskeleton, supporting cellular structure and motility
-
Potentially reducing local inflammation, facilitating tissue recovery
These mechanisms are primarily observed in controlled laboratory models.
Important Note
This page is provided for educational and scientific purposes only.
-
TB-500 is not approved for therapeutic, diagnostic, or cosmetic use.
-
Its use should be restricted to qualified laboratory or research settings under proper regulatory oversight.
| Dose |
10mg ,20mg ,30mg |
|---|
Related products
Bac Water
CJC-1295 No Dac
GHK-CU
Glow
MOTS-C
Retatrutide
Retatrutide is an investigational peptide drug that acts as a triple receptor agonist, targeting:
-
GLP-1 (glucagon-like peptide-1) receptors – influence glucose regulation and appetite
-
GIP (glucose-dependent insulinotropic polypeptide) receptors – enhance insulin secretion and metabolic signaling
-
Glucagon receptors – modulate energy expenditure and lipid metabolism

Reviews
There are no reviews yet.